SELLAS Life Sciences Group, Inc.
Income Statement
| Line Item | FY2011 |
|---|---|
| Revenue | $0 |
| Cost of Revenue | $0 |
| Gross Profit | $0 |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $3.9M |
| SG&A Expense | $8.6M |
| Operating Income | $-12.5M |
| Operating Margin | — |
| Interest Expense | — |
| Pretax Income | $-3.4M |
| Income Tax Expense | — |
| Net Income | $-11.5M |
| Net Margin | — |
| EPS (Basic) | $-0.16 |
| EPS (Diluted) | $-0.16 |
| Shares Outstanding (Basic) | 94.3M |
| Shares Outstanding (Diluted) | 94.3M |
| Dividends Per Share | — |